Deutsche Bank’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7
Closed 5335
2017
Q3
$0 Hold
7
﹤0.01% 5272
2017
Q2
$0 Hold
7
﹤0.01% 5289
2017
Q1
$0 Hold
7
﹤0.01% 5262
2016
Q4
$0 Hold
7
﹤0.01% 5209
2016
Q3
$0 Hold
7
﹤0.01% 5420
2016
Q2
$0 Buy
+7
New +$11 ﹤0.01% 5475
2015
Q4
Sell
-516
Closed 5507
2015
Q3
$0 Sell
516
-35,101
-99% -$39.8K ﹤0.01% 5474
2015
Q2
$50K Buy
35,617
+35,001
+5,682% +$85.7K ﹤0.01% 4600
2015
Q1
$2K Sell
616
-5,000
-89% -$17K ﹤0.01% 5005
2014
Q4
$17K Buy
5,616
+5,000
+812% +$24.8K ﹤0.01% 5566
2014
Q3
$4K Sell
616
-32,105
-98% -$263K ﹤0.01% 5587
2014
Q2
$341K Buy
32,721
+30,048
+1,124% +$256K ﹤0.01% 3767
2014
Q1
$24K Buy
2,673
+1,460
+120% +$8.65K ﹤0.01% 4789
2013
Q4
$5K Buy
+1,213
New +$5.67K ﹤0.01% 5042

Deutsche Bank's BSTG Position: Q4 2017 in Review

Deutsche Bank sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 7 shares.

Deutsche Bank first reported a position in BSTG in Q4 2013 and held it in 14 quarters. The position peaked at $341K in Q2 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

  • Deutsche Bank reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Deutsche Bank sold 7 Biostage, Inc. Common Stock shares in Q4 2017.
  • Deutsche Bank first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • Deutsche Bank's Biostage, Inc. Common Stock position peaked at $341K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.